Original Article | J Adv Med Biomed Res. 2020; 28(130): 284-290
Journal of Advances in Medical and Biomedical Research | ISSN:2676-6264
Assessment of Different Manifestations of Known Cases of Behçet’s Disease
Fatemeh Owlia 1
, Zahra Khodaei-Ardakani 2*
, Hosein Soleimanisaleh-Abadi 3
1. Dept. of Oral and Maxillofacial Medicine, School of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2. School of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3. Dept. of Rheumatology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Article Info
ABSTRACT
10.30699/jambs.28.130.284
Received: 2020/05/23;
Accepted: 2020/07/14;
Published Online: 30 Sep 2020;
Use your device to scan and read the
article online
Corresponding Information:
Zahra Khodaei-Ardakani,
School of Dentistry, Shahid Sadoughi
University of Medical Sciences, Yazd,
Iran
E-Mail: dr.owlia@gmail.com
Background & Objective:
Behçet’s disease (BD) is a multisystemic
inflammatory vascular disorder with an autoimmune background. It is a genetic
disease which can be affected by environmental factors. Behçet’s disease may
involve different organs like urogenital system, skin, eyes, and gastrointestinal
system. The prevalence of the disease varies considering the geographic area and
genetic predisposition. This study aims to evaluate some clinical features of mucocutaneous lesions of BD.
Materials & Methods: This cross-sectional study was done on 43 patients with BD
(24 men, 19 women). Age, sex, disease duration, and history of receiving medication
were investigated. The self-reported questionnaire was completed by participants.
Skin manifestations and genital and ocular involvements were also documented.
Results: Male to female ratio was measured 1.26:1. Oral aphthous commonly
localized on the lips. Ocular involvements and skin lesions prevalence percentages
were 76% and 48%, respectively. There was a statically significant correlation
between ocular lesions and age. Skin lesions and the frequency of oral aphthous per
year had a significant relationship. There also was a significant relationship between
the incidence of ocular lesions and skin lesions.
Conclusion: Oral aphthous, the most popular manifestation of BD, is the hallmark
of diagnosis. Thus, patients with oral aphthous require close surveillance for other
manifestations of BD for timely diagnosis and reference to a rheumatologist.
Keywords: Aphthous, Behcets syndrome, Eye manifestations, Genitalia, Skin
manifestations, Stomatitis.
Copyright © 2020, This is an original open-access article distributed under the terms of the Creative Commons Attribution-noncommercial 4.0 International License which permits
copy and redistribution of the material just in noncommercial usages with proper citation.
Introduction
Behçet’s disease (BD) is a chronic vascular immunemediated disease. The etiology of the disease is not
completely recognized (1-8). BD can be found
anywhere throughout the world; however, it is more
prevalent in countries along the ancient Silk Road such
as Turkey, Iran, Iraq, and Japan. The pattern of BD
depends on race (1, 3, 4). Initially published in 1937,
BD criteria included triad signs: recurrent oral
aphthous, genital ulcer, and ocular involvement (1-3, 6,
9-11). Strong association of BD with HLA-B51 has
been confirmed in many different ethnic groups from
the Middle East to the Far East, and about 40–80% of
mentioned patients possess HLA-B5 or B51 (12-16).
BD is a multisystemic disease with prominent
manifestation of oral aphthous. This finding usually
appears as the first symptom, followed by genital
ulcers, skin lesions and ocular involvement (1-8).
Sometimes, BD is accompanied by arthralgia, arthritis,
intestinal ulceration and CNS complications (1).
Volume 28, September & October 2020
The most recent international criteria for BD were
approved in 2006 in which scoring four points or more
was strongly suggestive of BD. Each of oral, ocular and
genital ulcers were allocated two points while skin
lesions, neurologic, and vascular manifestations had a
score of one. Despite being optional, a positive
pathergy test also has a score of one (6, 8).
According to the recent criteria, oral aphthous ulcers
are considered the main components of the disease (1-4,
10, 17-20). The first BD symptom is usually observed
when patients are in their 30s or 40s. The sooner the
disease begins, the more severe the disease will be, and
the longer it will take to recover (1-4, 6, 10, 18-22).
Behçet’s disease manifestation differs between races and
sexes (1, 5, 23, 24). In Middle East, men are more
susceptible in contrast to Japan and Korea (1, 2, 25-27).
Materials and Methods
A total of 43 consecutive BD patients composed of
24 males and 19 females took part in this study. They
Journal of Advances in Medical and Biomedical Research
Fatemeh Owlia et al. 285
were followed at a private rheumatologic clinic and met the
inclusion criteria. They were included in the study from
July to November 2018. All patients agreed to participate
in the study and signed a letter of informed consent. After
gathering a comprehensive history, participants’ data were
collected. Mentioned data included patients’ age, sex,
disease duration, and history of receiving medication. The
questionnaires were completed by the participants
themselves. They were asked about the clinical
characteristics of the disease (number, location, and size of
oral ulcers). Skin manifestations and genital and ocular
involvement were also documented. After filling out the
questionnaire, an oral examination was performed by a
trained senior dentistry student to determine each
participant’s oral health status.
The inclusion criteria were as follows: Regular visits
by the related specialist, having a complete medical
document, and disease duration of more than one year.
Patients with poor oral hygiene, tobacco use, or a
simultaneous disease with a probable manifestation of
aphthous ulcers (e.g. anemia, celiac, or inflammatory
bowel disease) were excluded from the study.
Our study was approved by the ethics committee of
Yazd Shahid Sadoughi University of medical sciences
(IR.SSU.REC.13970037).
The obtained data were analyzed using SPSS 17. The
chi-square and Fisher exact tests were used.
Differences were defined as statistically significant at
P<0.05.
Figure 1. Oral and labial manifestations of BD patients
Figure 2. Skin involvement in BD patient
Volume 28, September & October 2020
Journal of Advances in Medical and Biomedical Research
286 Assessment of Different Manifestations of Known Cases of Behçet’s Disease
Figure 3. Eye involvement in BD patient
Results
Men accounted for 24 of the 43 study patients, and
women accounted for 19. The male to female ratio was
determined to be 1.26:1. Patients’ ages ranged from 19
to 64 years. BD was mostly prevalent among the 40-49
age group (39.5%) and least common in participants
who were under 30 (4.7%). Oral aphthous were evident
in 100% of patients. They were commonly localized on
the lips (46.5%) and buccal mucosa (37.2%). It
occurred two to five times per year in 16 patients
(37.2%), less than twice per year in 16 patients
(37.2%), and more than five times per year in 11
patients (25.6%). When family history was evaluated,
six (13.9%) patients had a positive history of BD in
their family, and the others had either a negative or an
unknown history. Previous genital ulcers were
determined in 28 patients (65%). Ocular involvement
and skin lesions were reported in 76% and 48% of the
patients, respectively (Table 1).
Table 1. Some clinical features of the patients with BD
Variable data
classification
number
%
<1 year
0
0
1-5 year
1
2.3
>5 year
42
97.7
yes
6
14
no
37
86
<2
16
37.2
2-5
16
37.2
>5
11
25.6
Lip
20
46.5
Sublingual
6
14
Floor of mouth
1
2.3
cheek
16
37.2
Yes
28
65.1
No
15
34.9
Yes
33
76.7
No
10
23.3
Yes
21
48.8
No
22
51.2
Duration of disease
Familial history
Incidence of oral aphthous
lesion per year
location
Genital involvement
Ocular involvement
Skin involvement
Volume 28, September & October 2020
Journal of Advances in Medical and Biomedical Research
Fatemeh Owlia et al. 287
There was a statistically significant relationship
between skin lesions and the incidence of oral aphthous
ulcers per year (P=0.049) (Table 2) (Figures 1 and 2).
Patients with more frequent oral aphthous had more
skin lesions. Also, ocular involvement tended to occur
more frequently in patients older than 50 years
(P=0.038). More than half of the patients dealt with
ocular and genital involvements (76% and 65%,
respectively). Skin lesions were observed in 21 patients
(48.8%) (Table 3).
Table 2. Correlation between skin involvement and frequency of oral aphthous per year
Skin involvement
frequency of oral aphthous per year
Yes N (%)
No N (%)
<2
6(37.5)
10(62.5)
2-5
6(37.5)
10(62.5)
>5
9(81.8)
2(18.2)
Table 3. Correlation between clinical manifestations and age
<30
30-39
40-49
>50
N (%)
N (%)
N (%)
N (%)
Yes
1(50)
7(58.3)
14(82.4)
11(91.7)
No
1(50)
5(41.7)
3(17.6)
1(8.3)
Yes
1(50)
5(41.7)
9(52.9)
6(50)
No
1(50)
7(58.3)
8(47.1)
6(50)
Yes
1(50)
10(83.3)
11(64.7)
6(50)
no
1(50)
2(16.7)
6(35.3)
6(50)
age
manifestations
P value
ocular
0.038
skin
0.961
genital
0.367
Table 4. Correlation between skin lesions and ocular involvement.
Skin involvement
Ocular involvement
Total
N (%)
Yes
N (%)
No
N (%)
Yes
13(39.4)
20(60.6)
33(100)
No
8(80)
2(20)
10(100)
Frequency of skin lesions and genital involvement
did not increase with age.
Even though there was no statistically significant
relationship between skin lesions and genital
involvement, the relationship between ocular
involvement and skin lesions was significant. (P=0.034)
(Table 4).
Discussion
Therefore, occasional evaluation of BD characteristics
is of great importance even in the same country.
Although the small sample size of this study was one
of its limitations, the strict inclusion criteria were
applied to increase its accuracy. In this cross-sectional
study, the occurrence of some clinical manifestations
of BD was evaluated in an Iranian population. Despite
the limited population, this study is valuable since no
previous study has examined the clinical features of
BD in Yazd from a comprehensive point of view.
Many studies have been conducted about the clinical
features of BD in different countries. Due to the potent
role of genetics, its manifestation could vary across
different geographic areas and ethnic groups.
A notable advantage in the present study was ruling
out systemic diseases related to oral aphthous. This led
to more reliable results in comparison with previous
studies. The male to female ratio was 1.26/1. The
predilection for male involvement is similar to reports
Volume 28, September & October 2020
Journal of Advances in Medical and Biomedical Research
288 Assessment of Different Manifestations of Known Cases of Behçet’s Disease
by Davari (9) and Lennokove (23) but different than
California, US-based studies (28, 29).
Regarding the inclusion criteria, BD patients with a
disease duration of at least one year were included in
the study. Oral aphthous ulcers were seen in 100% of
patients, indicating that this is a hallmark of BD,
independent of patient demographics. It occurred more
than five times per year in 25.6% of patients. The
importance of family history is supported in the
literature (23). The occurrence frequency of oral
aphthous in the families was 14%. This is close to the
proportion detected in the analysis of Ugurlu et al. (30);
however, this percentage is lower than the percentages
reported in some previous studies (31, 32). This low
percentage may be due to the lack of knowledge about
family involvement among some patients.
Some studies ignored the location of oral aphthous
ulcers (1, 23, 31). In this study, oral aphthous
was mostly seen on the lips, followed by buccal
mucosa and tongue, respectively. This finding was in
accordance with the results of Alposy (2) and Cansu
(31), who stated that the tongue was the most common
involved location (31).
Genital ulcers were found in 28 patients (65.1%).
These results are in line with studies by Davatchi and
Sula (1, 33), who reported involvement rates of 64.4%
in Iran and 70% in Turkey. These percentages are less
than what Lennikoves reported in Russia (23). These
differences could be attributed to special HLA in some
races. It is worth mentioning that the results may be
underestimated due to the shame, fear, or disregard of
patients (33).
The frequency of ocular involvement in this study
was 76.7%. This ratio was higher than what was
reported in previous studies in Iran and Turkey (1, 33).
This may be attributed to the warm and dry weather of
geographic area of the study. Another reason could be
the higher incidence of ocular involvement in men in
this study (5). This finding is consistent with the Sula’s
findings, who reported the disease to be more common
in males and young patients (33).
Many of our patients were referred by
ophthalmologists, and they were diagnosed based on
ocular involvement in the advanced stage of BD. There
was a statistically significant relationship between age
and ocular involvement. Ocular involvement would
increase with aging (33). Regarding the high frequency
of ocular involvement in the BD patients,
ophthalmologic consultations should be considered
annually. These results indicated that the frequency of
oral aphthous can be used as a severity index for BD.
This was concluded because of the significant
relationship between skin lesions and the frequency of
oral aphthous per year. The more severe the disease,
the higher the possibility of involvement of organs in
the course of the disease.
Conclusion
Volume 28, September & October 2020
Oral aphthous, the most widespread manifestation of
BD, is the hallmark of BD diagnosis. Thus, patients
with oral aphthous require close surveillance for other
manifestations of BD. Timely diagnosis and reference
to Rheumatologists improves patients’ quality of life.
Ocular lesions can be affected by age. There was a
positive association between skin lesions and ocular
involvement.
Ethical considerations
Ethical issues (Including plagiarism, informed
consent, misconduct, data fabrication and/or
falsification, double publication and/or submission,
redundancy, etc.) have been completely observed by
the authors.
Acknowledgments
This study has been financially supported by Yazd
Shahid Sadoughi University of Medical Sciences Vice
Chancellor for Research and Technology.
Conflict of Interest
Authors declared no conflict of interest.
References
1.
Davatchi F, Chams-Davatchi C, Shams H, et al.
Behcet's disease: epidemiology, clinical
manifestations, and diagnosis. Expert Rev
ClinImmunol.
2017;13(1):57-65.
[DOI:10.1080/1744666X.2016.1205486]
2.
Alpsoy E. Behcet's disease: A comprehensive
review with a focus on epidemiology, etiology
and clinical features, and management of
mucocutaneous
lesions.
J
Dermatol.
2016;43(6):620-32.
[DOI:10.1111/13468138.13381]
3.
Esatoglu SN, Kutlubay Z, Ucar D, et al. Behcet's
syndrome: providing integrated care. J
Multidiscip
Health
Care2017;10:309-19.
[DOI:10.2147/JMDH.S93681]
4.
Khabbazi A, KarkonShayan F, Ghojazadeh M, et
al. Adherence to treatment in patients with
Behcet's disease. Int J Rheumat Dis.
2018;21(12):2158-66.
[DOI:10.1111/1756185X.13109]
5.
Kilian NC, Sawalha AH. Behcet's disease in the
United States: A single center descriptive and
comparative study. Europ J Rheumatol.
2017;4(4):239-44.
[DOI:10.5152/eurjrheum.2017.17112]
6.
Mat MC, Sevim A, Fresko I, Tuzun Y. Behcet's
disease as a systemic disease. ClinDermatol.
2014;32(3):435-42.
[DOI:10.1016/j.clindermatol.2013.11.012]
Journal of Advances in Medical and Biomedical Research
Fatemeh Owlia et al. 289
7.
8.
9.
Shahriyari E, Bonyadi M, JabbarpoorBonyadi
MH, Soheilian M, Yaseri M, Ebrahimiadib N.
Ubiquitin associated and SH3 domain containing
B (UBASH3B) gene association with Behcet's
disease in Iranian population. Curr Eye Res.
2019;44(2):200-5.
[DOI:10.1080/02713683.2018.1524913]
Scherrer MAR, Rocha VB, Garcia LC. Behcet's
disease: review with emphasis on dermatological
aspects. Anais brasileiros de dermatologia.
2017;92(4):452-64.
[DOI:10.1590/abd18064841.20177359]
Davari P, Rogers RS, Chan B, Nagler TH, Fazel
N. Clinical features of Behcet's disease: A
retrospective chart review of 26 patients. J
Dermatol
Treat.
2016;27(1):70-4.
[DOI:10.3109/09546634.2015.1054781]
10. Kiss E, Dohan J, Nemeth J, Poor G. Behcet's
disease: a rarely recognized orphan disorder.
Orvosihetilap.
2013;154(3):93-101.
[DOI:10.1556/OH.2013.29528]
11. Saccucci M, Di Carlo G, Bossu M, Giovarruscio
F, Salucci A, Polimeni A. Autoimmune diseases
and their manifestations on oral cavity: diagnosis
and clinical management. J Immunol Res.
2018;2018:6061825.
[DOI:10.1155/2018/6061825]
12. Munoz SA, Orden AO, Kostianovsky A, et al.
The HLA-B*51 allele is strongly associated with
Behcet disease in an argentinean population.
ReumatolClin.
2020;16(4):282-85
[DOI:10.1016/j.reuma.2018.07.002]
13. Maldini C, Lavalley MP, Cheminant M, de
Menthon M, Mahr A. Relationships of HLA-B51
or B5 genotype with Behcet's disease clinical
characteristics: systematic review and metaanalyses of observational studies. Rheumatol
(Oxford,
England).
2012;51(5):887-900.
[DOI:10.1093/rheumatology/ker428]
14. Ryu HJ, Seo MR, Choi HJ, Baek HJ. Clinical
phenotypes of Korean patients with Behcet
disease according to gender, age at onset, and
HLA-B51. Korean J Int Med. 2018;33(5):102531. [DOI:10.3904/kjim.2016.202]
15. Hamzaoui A, Houman MH, Massouadia M, et al.
Contribution of Hla-B51 in the susceptibility and
specific clinical features of Behcet's disease in
Tunisian
patients.
Europ
J
IntMed.
2012;23(4):347-9.
[DOI:10.1016/j.ejim.2011.12.011]
16. Demirseren DD, Ceylan GG, Akoglu G,
HLA-B51 subtypes in Turkish patients
Behcet's disease and their correlation
clinical manifestations. Genet Molec
2014;13(3):4788-96.
[DOI:10.4238/2014.July.2.8]
Volume 28, September & October 2020
et al.
with
with
Res.
17. The International Criteria for Behcet's Disease
(ICBD): a collaborative study of 27 countries on
the sensitivity and specificity of the new criteria.
J
EuropAcadDermatolVenereol
.
2014;28(3):338-47. [DOI:10.1111/jdv.12107]
18. Kanecki K, Nitsch-Osuch A, Gorynski P, Tarka
P, Kutera A, Tyszko P. Behcet disease: a rare
systemic vasculitis in Poland. Polish archives of
internal
medicine.
2017;127(10):652-6.
[DOI:10.20452/pamw.4160]
19. Wang ZK, Shi H, Wang SD, et al. Confusing
untypical intestinal Behcet's disease: Skip ulcers
with severe lower gastrointestinal hemorrhage.
World J GastrointestEndoscop. 2014;6(1):27-31.
[DOI:10.4253/wjge.v6.i1.27]
20. Zeidan MJ, Saadoun D, Garrido M, Klatzmann
D, Six A, Cacoub P. Behcet's disease
physiopathology: a contemporary review. Auto
Immun
Highlights.
2016;7(1):4.
[DOI:10.1007/s13317-016-0074-1]
21. Taylor J, Glenny AM, Walsh T, et al.
Interventions for the management of oral ulcers
in Behcet's disease. Cochrane Database System
Rev.
2014(9):Cd011018.
[DOI:10.1002/14651858.CD011018]
22. Tunes RS, Anjos TC, Martins GB, Barreto ER,
Santiago MB. Prevalence of Behcet's syndrome
in patients with recurrent aphthous ulcerations in
Brazil. Rheumatol Int. 2009;29(8):875-8.
[DOI:10.1007/s00296-008-0787-1]
23. Lennikov A, Alekberova Z, Goloeva R, et al.
Single center study on ethnic and clinical
features of Behcet's disease in Moscow, Russia.
ClinRheumatol.
2015;34(2):321-7.
[DOI:10.1007/s10067-013-2442-9]
24. Ghembaza ME, Bouabdallah N, Lounici A.
Behcet disease in Western Algeria. Medecine et
santetropicales.
2017;27(1):101-4.
[DOI:10.1684/mst.2017.0656]
25. Bergamo S, di Meo N, Stinco G, Bonin S,
Trevisini S, Trevisan G. Adamantiades-Behcet
disease at the beginning of the silk route: NorthEast
Italian
Experience.
ActadermatovenerolCroatica
:
ADC.
2017;25(4):295-7.
26. Suzuki T, Horita N, Takeuchi M, et al. Clinical
features of early-stage possible Behcet's disease
patients with a variant-type major organ
involvement in Japan. Modern Rheumatol.
2018:1-7.
27. Kim JN, Kwak SG, Choe JY, Kim SK. The
prevalence of Behcet's disease in Korea: data
from health insurance review and assessment
service from 2011 to 2015. Clin Experiment
Rheumatol. 2017;35Suppl 108(6):38-42.
Journal of Advances in Medical and Biomedical Research
290 Assessment of Different Manifestations of Known Cases of Behçet’s Disease
28. Sibley C, Yazici Y, Tascilar K, et al. Behcet
syndrome manifestations and activity in the
United States versus Turkey -- a cross-sectional
cohort
comparison.
J
Rheumatol.
2014;41(7):1379-84.
[DOI:10.3899/jrheum.131227]
29. Calamia KT, Wilson FC, Icen M, Crowson CS,
Gabriel SE, Kremers HM. Epidemiology and
clinical characteristics of Behcet's disease in the
US: a population-based study. Arthritis
Rheumatism.
2009;61(5):600-4.
[DOI:10.1002/art.24423]
30. Ugurlu N, Bozkurt S, Bacanli A, AkmanKarakas A, Uzun S, Alpsoy E. The natural
course and factors affecting severity of Behcet's
disease: a single-center cohort of 368 patients.
Rheumatol
Int.
2015;35(12):2103-7.
[DOI:10.1007/s00296-015-3310-5]
31. Cansu DU, Kasifoglu T, Korkmaz C. Do clinical
findings of Behcet's disease vary by gender?: A
single-center experience from 329 patients.
Europ
J
Rheumatol.
2016;3(4):157-60.
[DOI:10.5152/eurjrheum.2016.038]
32. Ozyurt K, Colgecen E, Baykan H. Does familial
occurrence or family history of recurrent oral
ulcers influence clinical characteristics of
Behcet's
disease?
ActadermatovenerologicaCroatica
:
ADC.
2013;21(3):168-73.
33. Sula B, Batmaz I, Ucmak D, Yolbas I, Akdeniz
S. Demographical and clin characteristics of
Behcet's disease in Southeastern Turkey. J Clin
Med
Res.
2014;6(6):476-81.
[DOI:10.14740/jocmr1952w]
How to Cite This Article:
Owlia F, Khodaei-ardakani Z, Soleymani saleh-abadi H. Assessment of Different Manifestations of Known
Cases of Behçet’s Disease. J Adv Med Biomed Res. 2020; 28 (130) :284-290
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mendeley
Zotero
Volume 28, September & October 2020
RefWorks
Journal of Advances in Medical and Biomedical Research